Assetmark Inc. Boosts Stake in McKesson Corporation $MCK

Key Points

• Assetmark Inc. increased its stake in McKesson by 34.0% in Q4 to 36,158 shares, valued at $29.66 million.
• Corporate insiders have sold 3,592 shares worth about $3.52 million over the past three months, and insiders now own just 0.08% of McKesson stock.
• Analysts are broadly positive with a consensus "Moderate Buy" and a $970.93 price target; McKesson beat Q results (EPS $9.34 vs. $9.19; revenue $106.16B, +11.4% YoY) and set FY2026 EPS guidance of $38.80–$39.20.

Assetmark Inc. lifted its holdings in McKesson Corporation (NYSE:MCK - Free Report) by 34.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 36,158 shares of the company's stock after purchasing an additional 9,167 shares during the quarter. Assetmark Inc.'s holdings in McKesson were worth $29,660,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also recently modified their holdings of the business. State Street Corp grew its holdings in shares of McKesson by 0.9% in the third quarter. State Street Corp now owns 5,750,519 shares of the company's stock worth $4,447,110,000 after acquiring an additional 51,510 shares during the period. Franklin Resources Inc. grew its holdings in shares of McKesson by 3.5% in the third quarter. Franklin Resources Inc. now owns 2,681,321 shares of the company's stock worth $2,071,428,000 after acquiring an additional 90,948 shares during the period. Alliancebernstein L.P. grew its holdings in shares of McKesson by 5.6% in the third quarter. Alliancebernstein L.P. now owns 2,394,699 shares of the company's stock worth $1,850,001,000 after acquiring an additional 126,684 shares during the period. Northern Trust Corp grew its holdings in shares of McKesson by 0.4% in the third quarter. Northern Trust Corp now owns 1,532,856 shares of the company's stock worth $1,184,193,000 after acquiring an additional 6,613 shares during the period. Finally, Boston Partners grew its holdings in shares of McKesson by 6.7% in the third quarter. Boston Partners now owns 1,330,953 shares of the company's stock worth $1,027,569,000 after acquiring an additional 83,357 shares during the period. Hedge funds and other institutional investors own 85.07% of the company's stock.

Insider Transactions at McKesson

In related news, Director Maria Martinez sold 349 shares of the stock in a transaction that occurred on Thursday, February 19th. The stock was sold at an average price of $939.87, for a total transaction of $328,014.63. Following the completion of the transaction, the director directly owned 301 shares of the company's stock, valued at approximately $282,900.87. This represents a 53.69% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the stock in a transaction that occurred on Friday, February 6th. The shares were sold at an average price of $955.00, for a total value of $313,240.00. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 3,592 shares of company stock valued at $3,518,555 over the last three months. Corporate insiders own 0.08% of the company's stock.

Wall Street Analysts Forecast Growth

Several analysts recently commented on MCK shares. Robert W. Baird set a $968.00 price objective on McKesson in a report on Wednesday, January 14th. Wells Fargo & Company lifted their price objective on McKesson from $914.00 to $925.00 and gave the stock an "equal weight" rating in a report on Thursday, February 5th. JPMorgan Chase & Co. lifted their price objective on McKesson from $983.00 to $1,107.00 and gave the stock an "overweight" rating in a report on Tuesday, February 10th. Evercore reaffirmed an "outperform" rating on shares of McKesson in a report on Thursday, March 5th. Finally, Bank of America cut their price target on McKesson from $1,040.00 to $1,000.00 and set a "buy" rating for the company in a report on Monday, April 6th. Thirteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $970.93.

McKesson Stock Performance

NYSE:MCK opened at $862.09 on Thursday. The stock has a 50-day simple moving average of $917.65 and a two-hundred day simple moving average of $853.54. McKesson Corporation has a 52-week low of $637.00 and a 52-week high of $999.00. The firm has a market capitalization of $105.60 billion, a PE ratio of 24.79, a P/E/G ratio of 1.24 and a beta of 0.42.

McKesson (NYSE:MCK - Get Free Report) last announced its quarterly earnings data on Wednesday, February 4th. The company reported $9.34 EPS for the quarter, beating the consensus estimate of $9.19 by $0.15. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The business had revenue of $106.16 billion for the quarter, compared to the consensus estimate of $105.98 billion. During the same period in the previous year, the business earned $8.03 earnings per share. The business's revenue was up 11.4% on a year-over-year basis. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. Equities analysts forecast that McKesson Corporation will post 32.77 earnings per share for the current fiscal year.

McKesson Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, April 1st. Stockholders of record on Monday, March 2nd were given a $0.82 dividend. This represents a $3.28 annualized dividend and a dividend yield of 0.4%. The ex-dividend date was Monday, March 2nd. McKesson's payout ratio is presently 9.43%.

McKesson Profile

McKesson Corporation NYSE: MCK is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company's core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.